Private Capital Group, LLC Dbv Technologies S.A. Transaction History

Private Capital Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$6.75 - $11.15 $10,125 - $16,725	-1,500 Closed	0 $0
Q1 2018 May 16, 2018	BUY	$20.86 - $26.6 $29,746 - $37,931	1,426 Added 1927.03%	1,500 $35,000
Q4 2017 May 18, 2018	SELL	$20.9 - $49.36 $15,737 - $37,168	-753 Reduced 91.05%	74 $37,000
Q4 2017 Mar 07, 2018	BUY	$20.9 - $49.36 $17,284 - $40,820	827	827 $36,000

253K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $131M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Capital Group, LLC with notifications on news.